Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies
| Image |  |
|---|---|
| Description | scientific article published on 17 April 2018 |
| Author/s |
author: Philip A Thompson Tapan M Kadia |
| Publication date | April 17, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |